Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „CYP3A4“
Suchtreffer
Begriffe & Kennungen
Adempas · 4.5 · The concomitant use of riociguat with strong CYP3A4 inducers (e.g. phenytoin, carbamazepine, phenobarbitone or
Eintrag öffnenAdvagraf · 4.5 · Effect of tacrolimus on the metabolism of other medicinal products Tacrolimus is a known CYP3A4 inhibitor; thu
Eintrag öffnenAdvagraf · 4.5 · Metabolic interactions Systemically available tacrolimus is metabolised by hepatic CYP3A4. There is also evide
Eintrag öffnenAfinitor · 4.5 · 9 Potent and moderate CYP3A4 inducers Rifampicin AUC ↓63% Avoid the use of concomitant (range 0-80%) potent CY
Eintrag öffnenAfinitor · 4.5 · CYP3A4 and PgP inducers decreasing everolimus concentrations
Eintrag öffnenAfinitor · 4.5 · CYP3A4 and PgP inhibitors increasing everolimus concentrations
Eintrag öffnenAfinitor · 4.5 · Everolimus is a substrate of CYP3A4, and also a substrate and moderate inhibitor of PgP. Therefore, absorption
Eintrag öffnenAfinitor · 4.5 · Known and theoretical interactions with selected inhibitors and inducers of CYP3A4 and PgP are listed in Table
Eintrag öffnenAfinitor · 4.5 · Substances that are inducers of CYP3A4 or PgP may decrease everolimus blood concentrations by increasing metab
Eintrag öffnenAfinitor · 4.5 · Substances that are inhibitors of CYP3A4 or PgP may increase everolimus blood concentrations by decreasing met
Eintrag öffnenAkeega · 4.5 · Effects of other medicinal products on niraparib or abiraterone acetate CYP3A4 inducers and inhibitors Abirate
Eintrag öffnenAkynzeo · 4.5 · 20 In humans, netupitant is eliminated mainly by hepatic metabolism mediated by CYP3A4 with a marginal renal e
Eintrag öffnenAkynzeo · 4.5 · 38 In humans, netupitant is eliminated mainly by hepatic metabolism mediated by CYP3A4 with a marginal renal e
Eintrag öffnenAkynzeo · 4.5 · Administration of the CYP3A4 inducer rifampicin with Akynzeo alone decreased the AUC of netupitant 5.2 fold an
Eintrag öffnenAkynzeo · 4.5 · Administration of the CYP3A4 inhibitor ketoconazole with netupitant/palonosetron capsules administered orally
Eintrag öffnenAkynzeo · 4.5 · Administration of the CYP3A4 inhibitor ketoconazole with netupitant/palonosetron capsules administered orally
Eintrag öffnenAkynzeo · 4.5 · Administration of the CYP3A4 inhibitor ketoconazole with netupitant/palonosetron capsules increased the AUC of
Eintrag öffnenAkynzeo · 4.5 · Effect of ketoconazole and rifampicin 56 Administration of the CYP3A4 inhibitor ketoconazole with netupitant/p
Eintrag öffnenAkynzeo · 4.5 · In humans, netupitant is eliminated mainly by hepatic metabolism mediated by CYP3A4 with a marginal renal excr
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnen